The Latest Breaking News from FDA

Brit man, 43, dies after taking notorious US 'zombie drug' in grim new UK first

A British man has become the first confirmed to have died after taking powerful drug Xylazine, dubbed the zombie drug, in the UK after dozens across the United States

Daily Mirror · May 24, 2023

GOP moves to limit abortion pill in US

A House panel advanced a 2024 budget bill that would block the ability to access the abortion drug via telehealth

Salon · May 24, 2023

This tech CEO is swapping blood with his 17-year-old son to stay young

This CEO is going to against the better judgment of the FDA to remain youthful.

Fortune · May 23, 2023

Four die from rare strain of bacteria that can 'melt' through eyeballs

The Centres for Disease Control and Prevention (CDC) confirmed the number of patients treated for the drug-resistant strain of Pseudomonas aeruginosa has now risen to 81 patients in 18 states

Daily Mirror · May 22, 2023

What is fezolinetant? The non-hormonal menopause treatment drug explained

The FDA-licensed drug could be approved for use in the UK by the end of the year

The Independent UK · May 22, 2023

More dogs welcomed in outdoor dining spaces, but not everyone is happy

The FDA’s updated food code, restaurants should have signs saying dogs are welcome and should develop plans to handle dogs and their waste. They should provide separate food bowls so dogs don’t use plates or utensils meant for humans.

Chicago Sun-Times · May 22, 2023

Medical AI's weaponization

Intentionally deadly bugs and toxins and misinformation are some key fears.

Axios · May 22, 2023

With growing abortion restrictions, Democrats push for over-the-counter birth control

With abortion increasingly restricted in many states, Sen. Patty Murray (D-Wash.), hopes to persuade Republicans to back insurance coverage for over-the-counter birth control.

WEKU · May 22, 2023

Commentary: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Chicago Tribune · May 22, 2023

The Crown Prosecution Service isn’t ‘cherrypicking’. It’s making the right calls

Letters: In all the domestic abuse cases where the CPS took no further action, it had made the right decision, says chief inspector Andrew T Cayley, while Duncan Woodhead of the FDA union also rejects claims of ‘cherrypicking’

The Guardian - UK · May 21, 2023